-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Ocular Therapeutix, Maintains $15 Price Target

Benzinga·03/04/2025 11:51:09
Listen to the news
HC Wainwright & Co. analyst Yi Chen reiterates Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $15 price target.